North American perspective of antiplatelet agents.
Gorelick
Philip B
PB
Department of Neurosciences, Rush Medical College, Chicago, Illinois, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D016894:Endarterectomy, Carotid; D006801:Humans; D009656:North America; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D055502:Secondary Prevention; D020521:Stroke / Q000191:economics / Q000517:prevention & control*
D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin